LONDON, UK — GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Affinivax, Inc (Affinivax), a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered… Read More
First new treatment regimen in more than 20 years to significantly improve outcomes in people with this fast-growing type of lymphoma Application is based on pivotal data from the phase… Read More
BioTalent Canada has launched its first 45 National Occupational Standards (NOS) for Canada’s bio-economy. These standards were validated by industry stakeholders and will replace BioTalent Canada’s Skills Profiles and Skills At-A-Glances…. Read More
WALTHAM, MASS. & DUBLIN– Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced that they have entered into a… Read More
Elecsys IGRA SARS-CoV-2 test supports the better understanding of immune response to SARS-CoV-2 infection or vaccination The test detects T-cell response, which may play an important role in determining if immune protection has… Read More
